comparemela.com
  1. Home
  2. Live Updates
  3. Vie Product - Breaking News

Latest Breaking News On - Vie product - Page 1 : comparemela.com

AbbVie Expands Immunology Portfolio in Canada as Health Canada approves SKYRIZI® (risankizumab) for the Treatment of Adults with Active Psoriatic Arthritis

/CNW/ - AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, announced Health Canada has approved SKYRIZI® (risankizumab), for the treatment.

Clin rheumatolEileen murphyTracey ramsayHealth canadaAmerican college of rheumatologyVice presidentGeneral managerAllergan aestheticsAbbvie canadaWeek results fromActive psoriatic arthritisIncluding patients with inadequate responseBiologic therapiesPract res clinVie product

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.